Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
EMD Serono
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Recurrent non-small cell lung, colorectal, ovarian or prostate cancer
No more than two lines of prior chemotherapy
Positive EpCAM expression
Karnofsky Performance Status \> 70%
Adequate laboratory results
Normal cardiac stress test
You may not be if
Evidence of brain metastases
Pregnant or lactating females
Significant infection
Prior receipt of EMD 273066
Unable to interrupt anti-hypertensive medications 2 days prior to and through each cycle of study medication administration
Uncontrolled hypertension
Previous diagnosis of Addison's disease
Previous diagnosis of an autoimmune disease
Organ transplant
Insulin-dependent diabetes
History of acute pancreatitis
Congestive heart failure
Clareo Health | EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide
